We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 565

Life Sciences 2016 Year in Review
  • Bereskin & Parr LLP
  • Canada, USA
  • February 21 2017

This article summarizes Canadian developments in the past year relating to the protection of Life Science innovations. CETA signed - Patent term


2016 Copyright Year in Review
  • Bereskin & Parr LLP
  • Canada, United Kingdom, USA
  • February 14 2017

Below are our selections of the most interesting developments in Canadian Copyright Law in 2016 from documentaries, toys, building plans, surveys


Sears' new mattress slogan put to bed by Federal Court
  • Bereskin & Parr LLP
  • Canada
  • February 13 2017

The Canadian Federal Court rarely grants interlocutory injunctions in trademark cases, but for the second time in two years, an interlocutory


Implementation of Trademarks Act Amendments - Now Scheduled for 2019: What This Means For Brand Owners
  • Bereskin & Parr LLP
  • Canada
  • February 8 2017

The Canadian Intellectual Property Office has confirmed that it now plans to implement the amendments to the Trademarks Act in early 2019. These will


Initial Interest Confusion: Vancouver Community College v. Vancouver Career College
  • Bereskin & Parr LLP
  • Canada
  • February 6 2017

Initial interest confusion is aimed primarily at regulating the use of keywords in Internet trading, i.e. Words typed by a user into the search field


Patents - Year in Review
  • Bereskin & Parr LLP
  • Canada
  • January 31 2017

In 2016 we discussed a number of interesting patent cases. Leaving aside cases directed toward features related specifically to pharmaceuticals or to


Two years of Canada’s Counterfeit Border Protection Measures Regime
  • Bereskin & Parr LLP
  • Canada
  • January 27 2017

The “Request For Assistance” (RFA) program, part of Canada’s new Border Protection regime to combat the import of counterfeit products, celebrated


Ongoing Infringement Must be Parsed to Determine Relevant Limitation Periods
  • Bereskin & Parr LLP
  • Canada
  • January 24 2017

In the recent decision of Apotex Inc v AstraZeneca Canada Inc 2017 FCA 9 relating to the drug omeprazole, the Federal Court of Appeal held that in


Cialis Canadian Patent Knocks Out Double Patenting Challenge
  • Bereskin & Parr LLP
  • Canada
  • January 20 2017

Eli Lilly's Canadian patent on treatment of erectile dysfunction with Cialis continues to defy all challengers. A recent appeal case originated from


Industrial Design Changes
  • Bereskin & Parr LLP
  • Canada
  • January 20 2017

On January 16, 2017, the Canadian Intellectual Property Office (CIPO) announced changes to practice under Canada's Industrial Design Act.1 These